SummaryA first-of-its-kind gene therapy has shown encouraging results in slowing the progression of Huntington’s disease, a rare and devastating brain disorder. Early trial data suggests improvements across movement, cognition, and daily function, with potential long-term impact. While regulatory reviews are still pending, the findings offer new hope for patients and families.